The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2021
DOI: 10.1016/j.jocn.2021.06.033
|View full text |Cite
|
Sign up to set email alerts
|

Volumetric growth of residual meningioma – A systematic review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
7
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 27 publications
0
7
0
Order By: Relevance
“… 56 The growth potential of residual meningioma is unclear, but the relative growth rate appears to be less than 15% per annum. 57 …”
Section: Managementmentioning
confidence: 99%
“… 56 The growth potential of residual meningioma is unclear, but the relative growth rate appears to be less than 15% per annum. 57 …”
Section: Managementmentioning
confidence: 99%
“…Despite this, there is scarce reporting of volumetric rather than two-dimensional measurements. 6 The slow adoption of volumetric MRI sequences is due to marginally increased acquisition times, increased workload for reporting radiologists and increased incidental findings. The advantages of volumetric studies include increased lesion 1 conspicuity (with more accurate delineation of tumour volume) and co-registration techniques to allow direct comparison.…”
Section: Imaging In the Management Of Intracranial Meningiomamentioning
confidence: 99%
“…The Incidental Meningioma: Prognostic Analysis using patient Comorbidity and MRI Tests (IMPACT) score is a system for using baseline clinical and radiographic features to categorize patients into three distinct prognostic categories. IMPACT can be used to assess risk for future growth and has an online calculator ( ) that is easily used [ 112 , 113 , 114 , 115 , 116 ]. Abnormally quick interval growth (or growth above a pre-determined threshold volume), concerning imaging features suggestive of higher grade, or younger patient age may precipitate treatment in an otherwise asymptomatic patient.…”
Section: Clinical Managementmentioning
confidence: 99%